Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 32 resultados

BIGPICTURE: Central Repository for Digital Pathology INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to crea...
2020-11-26 - 2027-01-31 | Financiado

T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR engineered T cell therapy INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative...
2020-11-24 - 2025-12-31 | Financiado

PREMIER: Prioritisation and Risk Evaluation of Medicines in the EnviRonment INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2019-17-two-stage There are around 1900 active pharmaceutical ingredients (APIs) in use, yet the environmental risks of only a small proportion of these has b...
2020-06-24 - 2026-08-31 | Financiado

EU-PEARL: EU Patient cEntric clinicAl tRial pLatform INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company I...
2019-11-27 - 2023-04-30 | Financiado

IMMUcan: Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage IMMUcan proposes an inclusive and integrated European immuno-oncology platform. IMMUcan will access high-quality human biological material...
2019-04-23 - 2025-08-31 | Financiado

NECESSITY: NEw Clinical Endpoints in primary Sjögren s Syndrome an Interventional Trial based on stratifYing p... INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease (AID) involving 0.5 to 3/1000 persons. The disease affects exocrine glands...
2018-12-18 - 2025-12-31 | Financiado

EHDEN: European Health Data and Evidence Network INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health...
2018-11-22 - 2024-10-31 | Financiado

c4c: conect4children COllaborative Network for European Clinical Trials For Children INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2016-10-two-stage Paediatric medicines development is embedded in the European policy, legislation and in the work of the pharmaceutical industry but currentl...
2018-06-22 - 2025-04-30 | Financiado

PARADIGM: Patients Active in Research and Dialogues for an Improved Generation of Medicines Advancing meaning... INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2016-10-two-stage PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engage...
2018-06-04 - 2020-11-30 | Financiado

INSIST: IN Silico trials for treatment of acute Ischemic STroke INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-SC1-2016-2017 Stroke is the number one cause of disability in the Western world and the 3rd most common cause of death. Despite new treatment options with...
2017-10-16 - 2022-04-30 | Financiado

eTRANSAFE: Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sh...
2017-09-12 - 2023-02-28 | Financiado

BigData Heart: Big Data 4 Better Hearts Sofia ref. 116074 INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage Despite remarkable progress in the management of cardiovascular disease (CVD), major unmet needs remain with regard to mortality, hospitalis...
2017-06-26 - 2023-02-28 | Financiado

DO-IT: Big Data for Better Outcomes Policy Innovation and Healthcare System Transformation Sofia ref. 1... INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of...
2017-01-30 - 2019-01-31 | Financiado

TransQST: Translational quantitative systems toxicology to improve the understanding of the safety of medicine... INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage TransQST will develop a Quantitative Systems Toxicology (QST) approach, employing pre-existing data where possible, in order to yield new me...
2016-12-22 - 2022-08-31 | Financiado

REPROGRAM: Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other ch... INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-PHC-2014-2015 Up to 70% of cardiovascular events are not prevented by current therapeutic regimens. In search for additional, innovative strategies, immun...
2015-12-04 - 2019-12-31 | Financiado

ADAPT-SMART: Accelerated Development of Appropriate Patient Therapies a Sustainable Multi stakeholder Approach... INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un H2020: H2020-JTI-IMI2-2015-04-two-stage-Master Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major ad...
2015-09-02 - 2018-04-30 | Financiado

APPROACH: Applied Public-Private Research enabling OsteoArthritis Clinical Headway INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un FP6: The problem: finding the right patient for the right treatmentDespite a large and growing disease burden in osteoarthritis (OA), many pharma...
2015-06-01 - 2020-11-30 | Financiado

SPRINTT: Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un FP6: The current healthcare systems are built around the traditional paradigm of patients suffering from a single acute illness. They are theref...
2014-07-01 - 2020-04-30 | Financiado

PRECISESADS: Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un FP6: We concur to the IMI on Reclassification of SLE, connective tissue diseases and RA” call by presenting a proposal aimed at using the power o...
2014-02-01 - 2019-01-31 | Financiado

EMIF: European Medical Information Framework INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS participó en un FP6: In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected,...
2013-01-01 - 2018-06-30 | Financiado